LENZ Therapeutics, Inc. (LENZ) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
LENZ Therapeutics, Inc. (LENZ) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $252.4M, listed on NASDAQ, employing roughly 6 people, carrying a beta of 1.67 to the broader market. LENZ Therapeutics, Inc. Led by Evert Schimmelpennink, public since 2024-03-22.
Snapshot as of May 15, 2026.
- Spot Price
- $7.36
- ATM IV
- 121.4%
- IV Skew 25Δ
- 0.231
- IV Rank
- 54.9%
- IV Percentile
- 79.8%
- Term Structure Slope
- 0.126
As of May 15, 2026, LENZ Therapeutics, Inc. (LENZ) at-the-money implied volatility is 121.4%. IV rank is 54.9% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 79.8%. The 25-delta skew is +0.231: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
LENZ Strategy Selection at Current Volatility Levels
For LENZ Therapeutics, Inc. options at 121.4% ATM IV, mid-range IV rank (54.9%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked LENZ volatility skew questions
- What is the current LENZ ATM implied volatility?
- As of May 15, 2026, LENZ Therapeutics, Inc. (LENZ) at-the-money implied volatility is 121.4%. IV rank is 54.9% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is LENZ IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does LENZ volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. LENZ Therapeutics, Inc. shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.